Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.

scientific article published on 7 September 2015

Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1039/C5BM00204D
P698PubMed publication ID26343506

P50authorErmei MäkiläQ41554703
Nicolas H. VoelckerQ53412792
P2093author name stringS Apostolou
B J Kuss
B Delalat
F J Harding
J J Salonen
M Alnakhli
M Hasanzadeh Kafshgari
P2860cites workThe effect of tungstate nanoparticles on reactive oxygen species and cytotoxicity in Raw 264.7 mouse monocyte macrophage cellsQ23915936
Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretionQ28570070
Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systemsQ30476025
Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liverQ31967138
Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencingQ33831440
Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles.Q33902729
Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery.Q33945802
Nuclear pores and nuclear assemblyQ34245411
Small interfering RNA-based molecular therapy of cancersQ34552948
The blood-brain barrier and cancer: transporters, treatment, and Trojan horsesQ34577796
Biodegradable luminescent porous silicon nanoparticles for in vivo applicationsQ34684415
Early toxicity predicts long-term survival in high-grade gliomaQ35006910
Sustained small interfering RNA delivery by mesoporous silicon particlesQ35456065
siRNA-based approaches in cancer therapyQ36373107
Radiation dose-volume effects in the brain.Q36560171
Role of the MRP1/ABCC1 multidrug transporter protein in cancerQ37034313
Porous silicon in drug delivery devices and materialsQ37174934
High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeuticsQ37404528
Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructsQ37510528
Targeted drug delivery for treatment and imaging of glioblastoma multiformeQ37523966
Nanoparticle technologies for cancer therapyQ37706288
Enhancing endosomal escape for nanoparticle mediated siRNA deliveryQ38212473
Insights into cellular uptake of nanoparticlesQ38242078
Cancer-targeting siRNA delivery from porous silicon nanoparticlesQ39018787
Cell uptake enhancement of folate targeted polymer coated magnetic nanoparticlesQ39125334
Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles.Q39140983
5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cellsQ39308023
Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistributionQ39406359
The packaging of siRNA within the mesoporous structure of silica nanoparticles.Q39476515
Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitroQ39547831
Cytotoxicity of mesoporous silica nanomaterialsQ40012476
Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1.Q40561425
RNA interference in human cells is restricted to the cytoplasmQ40712353
Biodegradable silicon nanoneedles delivering nucleic acids intracellularly induce localized in vivo neovascularization.Q41140755
Nitric oxide-releasing porous silicon nanoparticles.Q42747168
Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escapeQ44591306
In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: a potential role in neuroblastoma therapyQ45714420
Controlled complexation of plasmid DNA with cationic polymers: effect of surfactant on the complexation and stability of the complexesQ46516640
Molecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1).Q46916652
Stimulus-responsiveness and drug release from porous silicon films ATRP-grafted with poly(N-isopropylacrylamide).Q53423878
From survival to survivorship: late side effects become an issue in high-grade glioma.Q55463799
Kinetic modeling: a predictive tool for the adsorption of zinc ions onto calcium alginate beadsQ59304281
P433issue12
P921main subjectnanoparticleQ61231
P304page(s)1555-1565
P577publication date2015-09-07
P1433published inBiomaterials ScienceQ27724497
P1476titleSmall interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles
P478volume3

Reverse relations

cites work (P2860)
Q36185176Combined bortezomib-based chemotherapy and p53 gene therapy using hollow mesoporous silica nanospheres for p53 mutant non-small cell lung cancer treatment.
Q52719561Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
Q53124973In Vitro Gene Delivery with Large Porous Silicon Nanoparticles Fabricated Using Cost-Effective, Metal-Assisted Chemical Etching.
Q48649312Micro-optical coherence tomography tracking of magnetic gene transfection via Au-Fe3O4 dumbbell nanoparticles
Q47607623Multiplexed nanomedicine for brain tumors: nanosized Hercules to tame our Lernaean Hydra inside?
Q38843670Powering up the molecular therapy of RNA interference by novel nanoparticles
Q90362515Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Q38714438Shape matters when engineering mesoporous silica-based nanomedicines.
Q48095060Use of nanoparticles for glioblastoma treatment: a new approach

Search more.